Search Ontology:
ChEBI

delavirdine

Term ID
CHEBI:119573
Synonyms
  • (N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide)
  • 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine
  • 2-(4-(5-methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine
  • Delavirdine
  • N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide
  • N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide
  • N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide
Definition
The amide resulting from the formal condensation of 5-[(methylsulfonyl)amino]-1H-indole-2-carboxylic acid and 4-amino group of 1-[3-(isopropylamino)pyridin-2-yl]piperazine, delavirdine is a non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. Viral resistance emerges rapidly when delavirdine is used alone, so it is therefore used (as the methanesulfonic acid salt) with other antiretrovirals for combination therapy of HIV infection.
References
  • cas:136817-59-9
  • drugbank:DB00705
  • drugcentral:799
  • kegg.compound:C06941
  • kegg.drug:D07782
  • patent:WO9109849
  • pdb-ccd:SPP
  • pubmed:11124228
  • pubmed:11225565
  • pubmed:11327199
  • pubmed:11363651
  • pubmed:11363709
  • pubmed:11364022
  • pubmed:11364099
  • pubmed:11364363
  • pubmed:11364481
  • pubmed:11590527
  • pubmed:16449090
  • pubmed:21080015
  • pubmed:21683601
  • pubmed:21865017
  • reaxys:6356813
  • wikipedia.en:Delavirdine
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from delavirdine
Phenotype where environments contain delavirdine
Phenotype modified by environments containing delavirdine
Phenotype affecting delavirdine
Human Disease Model